Dinesh ParmarPolyPeptide Group における Associate Director Regulatory Affairsスピーカー
アジェンダセッション
Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase
, 11:30amセッションを見る